PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

One of the largest studies on preterm birth finds a maternal biomarker test significantly reduces neonatal morbidities and improves neonatal outcomes

2025-01-31
(Press-News.org) UNDER EMBARGO UNTIL: Jan. 31, 2025, 10:15 a.m. MST 

Media Contact: Karen Addis, APR, karen@addispr.com, +1 (301) 787-2394

One of the Largest Studies on Preterm Birth Finds a Maternal Biomarker Test Significantly Reduces Neonatal Morbidities and Improves Neonatal Outcomes

Denver, Colo. ― Preterm birth ― defined as delivery before the 37th week of pregnancy — is one of the leading causes of infant deaths in the United States. Babies born prematurely are also at an increased risk of having serious health problems. Yet despite advancements in many areas of obstetrics, little progress has been made to reduce the number of preterm births or improve neonatal outcomes. For the third consecutive year, the March of Dimes Annual Report Card has given the United States a D+ for the country’s persistently high preterm birth rate. 

In a new study to be presented today at the Society for Maternal-Fetal Medicine’s (SMFM) annual meeting, The Pregnancy Meeting™, researchers will unveil findings that suggest that a biomarker test to identify pregnant people at higher risk of preterm birth significantly improved neonatal outcomes, including reducing infant morbidity as well as reducing admissions to the neonatal intensive care unit (NICU) and the amount of time spent in the NICU.

In a multicenter randomized controlled trial, researchers enrolled 5,018 pregnant people at low risk for preterm birth from 19 centers in the United States. Individuals with factors that increase the risk of preterm birth — such as a prior preterm birth, a short cervix, multiple gestations, or severe medical conditions such as lupus or chronic renal disease — were excluded from the trial thus examining a low-risk population.

The biomarker test, which analyzed a participant’s blood, was administered in the middle of the second trimester of pregnancy to identify individuals at higher risk of delivering an infant preterm. The test classified 23.5 percent of participants as higher risk within the preterm birth prevention arm. In addition to the traditional standard of care, individuals identified as high risk were given a low-risk and low-cost regimen of daily vaginal progesterone and low-dose aspirin and also assigned weekly standardized phone calls with a nurse. The remaining lower-risk participants received the usual standard of pregnancy care, which included routine checkups.

In the preterm birth prevention group that was screened and treated if the mother had a higher risk test result, data showed a 20 percent reduction in neonatal morbidity and a 20 percent reduction in NICU admissions. Results also further demonstrated that infants who were admitted to the NICU had a 6-8 percent reduction in the length of stay. 

“This study is the first to combine a biomarker test that screened a large segment of the population who do not have the typical risk factors for preterm birth with a targeted treatment plan for those who were identified to be at higher risk and demonstrated dramatic improvements in neonatal outcomes,” says the study’s lead author Brian Iriye, MD, a maternal-fetal medicine subspecialist and managing physician at the High Risk Pregnancy Center in Las Vegas. Iriye is also a past president of SMFM. “These findings suggest a transformative strategy for reducing neonatal complications and I believe has the ability to change the practice of obstetrics and prevent neonatal issues associated with preterm birth.”

The abstract was published in the January 2025 issue of Pregnancy, a new open-access journal and the first official journal for the Society for Maternal-Fetal Medicine.

Additional news releases about select SMFM research being presented are posted on AAAS’s EurekAlert (subscription needed) approximately one week in advance of embargo lifting. Embargoes lift on the date and start time of the abstract presentation.

Disclosure Statement

Sera Prognostics, Inc. sponsored the trial, providing the biomarker test (PreTRM®) and institutional funding to coordinate study site recruitment, interventions, and IRB services. The sponsor shared individual site management with Carelon Research. In addition, Elevance Health (formerly Anthem, Indianapolis, IN, USA) provided funding for biomarker testing in covered members who were enrolled in the trial.

# # #

About the Society for Maternal-Fetal Medicine

The Society for Maternal-Fetal Medicine (SMFM), founded in 1977, is the medical professional society for obstetricians who have additional training in high-risk, complicated pregnancies. SMFM represents more than 7,000 members who care for high-risk pregnant people and provides education, promotes research, and engages in advocacy to reduce disparities and optimize the health of high-risk pregnant people and their families. SMFM and its members are dedicated to optimizing maternal and fetal outcomes and assuring medically appropriate treatment options are available to all patients. For more information, visit SMFM.org and connect with the organization on Facebook, X, and Instagram. For the latest 2025 Annual Meeting news and updates, follow the hashtag #SMFM25.

END



ELSE PRESS RELEASES FROM THIS DATE:

One of the largest studies of its kind finds early intervention with iron delivered intravenously during pregnancy is a safe and effective treatment for anemia

2025-01-31
Denver, Colo. ― Anemia during pregnancy is a common occurrence and often due to iron deficiency. It is a global public health problem, affecting an estimated 37 percent of pregnant individuals, according to the World Health Organization. Iron deficiency anemia is associated with increased rates of pregnancy-related problems, such as going into labor prematurely, hemorrhaging and, in some cases, even death. For the infant, maternal iron deficiency also can have long-term implications on their overall health and development. Current obstetric guidelines recommend ...

New Case Western Reserve University study identifies key protein’s role in psoriasis

New Case Western Reserve University study identifies key protein’s role in psoriasis
2025-01-31
CLEVELAND—Psoriasis, a painful and uncomfortable inflammatory skin condition that affects millions worldwide, flares up from the activity of disease- and infection-protecting immune cells. In a new study, researchers at Case Western Reserve University School of Medicine have determined that a protein called NF-kB c-Rel can intensify the condition’s symptoms when activated by signals from the body’s immune system. Understanding how “c-Rel” affects skin inflammation could lead to new treatments, they said. The study, published recently in eBioMedicine, examined how ...

First-ever ethics checklist for portable MRI brain researchers

2025-01-31
MINNEAPOLIS/ST. PAUL (01/31/2025) — Portable MRI (pMRI) technologies are rapidly transforming the landscape of neuroscience research, allowing neuroscientists to acquire brain data in community settings outside the hospital for the first time. But as neuroscientists increase access to MRI technology and move their research from a lab environment to broad community settings, they face novel ethical, legal, and societal issues (ELSI). To prepare neuroscientists to address these challenges, an interdisciplinary team of scientists, ethicists, and legal experts, supported by an NIH BRAIN Initiative grant, analyzed the issues. The team released the first-ever checklist ...

Addressing 3D effects of clouds for significant improvements of climate models

Addressing 3D effects of clouds for significant improvements of climate models
2025-01-31
  Leipzig. Over the next few years, climate researchers from Germany aim to achieve a breakthrough in the radiative properties of clouds by describing the corresponding processes not just one-dimensionally, as has been the case up to now, but three-dimensionally in future. Capturing clouds and radiation in 3D is seen as an important step towards undistorted remote sensing of the atmosphere and improved modelling of climate and weather. The new research group of the German Research Foundation (DFG) brings together experts in atmospheric radiation, high-resolution ...

Gut microbes may mediate the link between drinking sugary beverages and diabetes risk

Gut microbes may mediate the link between drinking sugary beverages and diabetes risk
2025-01-31
It is well known that consuming sugary drinks increases the risk of diabetes, but the mechanism behind this relationship is unclear. Now, in a paper publishing January 31 in the Cell Press journal Cell Metabolism, researchers show that metabolites produced by gut microbes might play a role. In a long-term cohort of US Hispanic/Latino adults, the researchers identified differences in the gut microbiota and blood metabolites of individuals with a high intake of sugar-sweetened beverages. The altered metabolite profile ...

Ribosomes team up in difficult situations, new technology shows

Ribosomes team up in difficult situations, new technology shows
2025-01-31
Researchers from the Tanenbaum group at the Hubrecht Institute have developed a new microscopy technique to observe how ribosomes function in cells. With this method, they can monitor individual ribosomes as they convert mRNA into proteins. The researchers discovered that ribosomes help each other when encountering difficulties, a process they refer to as ‘ribosome cooperativity’. This technique and the findings, published in Cell, provide insights into how proteins are made and offer other researchers a tool to better study mRNA translation. Our DNA contains genetic information essential for ...

Mortality trends among adults ages 25-44 in the US

2025-01-31
About The Study: This cross-sectional study found that compared with trends from the early 2000s, early adult (ages 25-44) mortality in the U.S. has risen substantially in 2 stages: 2011 to 2019 and 2020 to 2023. Although mortality rates decreased after the core pandemic years, excess mortality remained higher than expected based on pre-pandemic levels. The largest portion of 2023 excess mortality was driven by drug poisoning, but many other external and natural causes exceeded what prior trends would have projected. Corresponding Author: To contact the corresponding author, Elizabeth Wrigley-Field, PhD, email ewf@umn.edu. To access the embargoed study: Visit our ...

Discontinuation and reinitiation of dual-labeled GLP-1 receptor agonists among us adults with overweight or obesity

2025-01-31
About The Study: In this cohort study, most patients with overweight or obesity discontinued glucagon-like peptide-1 receptor agonist (GLP-1 RA) therapy within 1 year, but those without type 2 diabetes had higher discontinuation rates and lower reinitiation rates. Inequities in access and adherence to effective treatments have the potential to exacerbate disparities in obesity.  Corresponding Author: To contact the corresponding author, Ezekiel J. Emanuel, MD, PhD, email zemanuel@upenn.edu. To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/ (doi:10.1001/jamanetworkopen.2024.57349) Editor’s ...

Ultraprocessed food consumption and obesity development in Canadian children

2025-01-31
About The Study: High ultraprocessed food consumption during early childhood was associated with obesity development, primarily in males in this cohort study of Canadian children. These findings can inform targeted public health initiatives for early childhood centers and caregiver education programs to reduce ultraprocessed food intake and prevent obesity.  Corresponding Author: To contact the corresponding author, Kozeta Miliku, MD, PhD, email kozeta.miliku@utoronto.ca. To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/ (doi:10.1001/jamanetworkopen.2024.57341) Editor’s Note: Please see the ...

Experts publish framework for global adoption of digital health in medical education

2025-01-31
A group of 211 international experts from 79 countries has today published a new framework to facilitate the design, development and implementation of digital health curricula in medical education worldwide. Published in JAMA Network Open, the Digital Health Competencies in Medical Education (DECODE) framework is designed to help medical institutions better equip future physicians for the ongoing digital transformation in healthcare. The framework is already beginning to be adopted across the globe, including in the UK where it has influenced ...

LAST 30 PRESS RELEASES:

The vast majority of US rivers lack any protections from human activities, new research finds

Ultrasound-responsive in situ antigen "nanocatchers" open a new paradigm for personalized tumor immunotherapy

Environmental “superbugs” in our rivers and soils: new one health review warns of growing antimicrobial resistance crisis

Triple threat in greenhouse farming: how heavy metals, microplastics, and antibiotic resistance genes unite to challenge sustainable food production

Earthworms turn manure into a powerful tool against antibiotic resistance

AI turns water into an early warning network for hidden biological pollutants

Hidden hotspots on “green” plastics: biodegradable and conventional plastics shape very different antibiotic resistance risks in river microbiomes

Engineered biochar enzyme system clears toxic phenolic acids and restores pepper seed germination in continuous cropping soils

Retail therapy fail? Online shopping linked to stress, says study

How well-meaning allies can increase stress for marginalized people

Commercially viable biomanufacturing: designer yeast turns sugar into lucrative chemical 3-HP

Control valve discovered in gut’s plumbing system

George Mason University leads phase 2 clinical trial for pill to help maintain weight loss after GLP-1s

Hop to it: research from Shedd Aquarium tracks conch movement to set new conservation guidance

Weight loss drugs and bariatric surgery improve the body’s fat ‘balance:’ study

The Age of Fishes began with mass death

TB harnesses part of immune defense system to cause infection

Important new source of oxidation in the atmosphere found

A tug-of-war explains a decades-old question about how bacteria swim

Strengthened immune defense against cancer

Engineering the development of the pancreas

The Journal of Nuclear Medicine ahead-of-print tip sheet: Jan. 9, 2026

Mount Sinai researchers help create largest immune cell atlas of bone marrow in multiple myeloma patients

Why it is so hard to get started on an unpleasant task: Scientists identify a “motivation brake”

Body composition changes after bariatric surgery or treatment with GLP-1 receptor agonists

Targeted regulation of abortion providers laws and pregnancies conceived through fertility treatment

Press registration is now open for the 2026 ACMG Annual Clinical Genetics Meeting

Understanding sex-based differences and the role of bone morphogenetic protein signaling in Alzheimer’s disease

Breakthrough in thin-film electrolytes pushes solid oxide fuel cells forward

Clues from the past reveal the West Antarctic Ice Sheet’s vulnerability to warming

[Press-News.org] One of the largest studies on preterm birth finds a maternal biomarker test significantly reduces neonatal morbidities and improves neonatal outcomes